The Neurological Institute of New York

CRITICAL CARE

Neurological Intensive Care

STEPHAN A. MAYER, DIRECTOR

Research interests include clinical trials and outcomes research in intracerebral and subarachnoid hemorrhage; multimodality brain neuromonitoring; therapeutic hypothermia; status epilepticus; neurocardiology; and bioethics

NEERAJ BADJATIA

Research interests include therapeutic hypothermia and normothermia; nutrition and metabolism; multimodality brain monitoring; anemia after non-traumatic brain injury; early goal directed resuscitation after traumatic brain injury

JAN CLAASSEN

Research interests include multimodality brain monitoring; ICU epilepsy and neurophysiology; clinical trials and outcomes research in status epilepticus; refractory status epilepticus; neuroimaging of acute brain injury.

KIWON LEE

Research focuses on the advanced cardiac and hemodynamic management for patients with acute subarachnoid hemorrhage (SAH) and cerebral vasospasm, cardiac output optimization for improving cerebral perfusion and brain tissue oxygenation, therapeutic hypothermia for acute ischemic stroke, intracerebral hemorrhage (ICH), and traumatic brain injury as well as refractory intracranial pressure crisis, intrathecal administration of vasoactive agents for refractory distal cerebal vasospasm after subarachnoid hemorrhage, and prothombic complex concentrate (PCC) and factor IX complex concentrate (FIXCC) for reversal of warfarin-induced coagulopathy in acute ICH.

MICHAEL SCHMIDT

Dr. Schmidt is the Director of the Neuro-ICU Neuromonitoring and Informatics program and the Columbia University Undergraduate Research Internship in Neurology and Neurosurgery. Dr. Schmidt's interests include: generation of patient-specific physiological targets and early detection of secondary complications related to critical brain injuries through real-time analysis of neurophysiological monitoring data; the use of clinical informatics to support patient management decisions within the intensive care unit; and identifying modifiable factors that drive health outcomes following critical brain injuries. His research as a co-investigator to determine patient status utilizing multimodal neuromonitoring data from critical brain injury patients was supported by the Dana Foundation.